Rhinomed Limited (RHNMF) and US Based Columbia Care LLC to Develop Nasally Delivered Dose Controlled Cannabis Based Medicines

Stock Information for Rhinomed Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Rhinomed Limited

Ethics Approval Granted for Clinical Trial of World's First Nasal Swab Designed Specifically for Children
Innovation Investor Conference Presentations Now Available for On-Demand Viewing
Rhinomed Ltd to Webcast Live at VirtualInvestorConferences.com December 3rd
Live Innovation Investor Conference & Webinar: Public Company Presentations December 3rd
Live Growth Opportunities Investor Conference October 8th
Global OTCQX Consumer and Resource Company Investor Presentations Now Available for On-Demand Viewing
Live Investor Conference & Webinar: A Global Portfolio of OTCQX Consumer and Resources Leaders Present December 4th and 5th
Live Investor Conference & Webinar: Executives from Resource, Retail, and Cannabis Companies Present December 4th and 5th

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.